Pacific Bio (PACB) Tops Q4 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q4 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $25.7 million versus the consensus estimate of $23.14 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lucid reports Q2 output, names new CFO and five other leaders
• AeroVironment (AVAV) Tops Q4 EPS by 36c